|Bid||37.30 x 800|
|Ask||39.21 x 900|
|Day's range||37.31 - 38.41|
|52-week range||35.10 - 64.37|
|Beta (5Y monthly)||1.07|
|PE ratio (TTM)||N/A|
|Forward dividend & yield||N/A (N/A)|
|1y target est||N/A|
Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) today announced that management will participate in virtual fireside chats at the following investor conferences:
Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) today announced that management will conduct its 2021 virtual Annual Meeting of Stockholders followed by a general corporate update on Wednesday, June 2, 2021. This event will be webcast live on the internet in place of an in-person meeting.
Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) today reported its financial results for the first quarter of 2021 and recent business highlights.